Where does Abbott Cardiovascular Systems, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Abbott Cardiovascular Systems, Inc. ranks #707 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Abbott Cardiovascular Systems, Inc. hold?

Abbott Cardiovascular Systems, Inc. holds 640 US utility patents granted between 2015 and 2025, spanning 65 technology areas.

What is Abbott Cardiovascular Systems, Inc.'s Innovation Score?

Abbott Cardiovascular Systems, Inc. has an Innovation Score of 60.8 out of 100 (top 3% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Abbott Cardiovascular Systems, Inc.'s patent grant rate increasing or decreasing?

Abbott Cardiovascular Systems, Inc.'s recent grant velocity is -81% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Abbott Cardiovascular Systems, Inc.'s patents?

Abbott Cardiovascular Systems, Inc.'s patents average 16.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Abbott Cardiovascular Systems, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Abbott Cardiovascular Systems, Inc.

Q: What technology areas does Abbott Cardiovascular Systems, Inc. focus on?

Abbott Cardiovascular Systems, Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 385 patents. Grants appear in 65 CPC subclasses total.

USPTO PatentsView assignee record - 640 granted patents across 65 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Abbott ranks #707 of 49,997 tracked US assignees by granted-patent volume, with 640 patents across 65 technology areas.

#707
of 49,997 US assignees by volume: Top 3%
by Innovation Score (60.8/100): 16.1
avg claims per patent: -81%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R707 · US Corporation #707 · 640 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MID 640 grants
TOP-DECILE #707/49,997
PHOTO-FINISH Mitsubishi Materials
CPC-WIDE A61F · 65 areas
INNOV-STRONG 60.8/100
CLAIMS-RICH 16.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -81% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Mitsubishi Materials Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
ConocoPhillips · near

61
The Government of… · near

61
Abbott Cardiovascula… · this assignee

61
Blue Yonder Group · near

61
Zhejiang University… · near

61
3D Lighting… · lowest

7

What this shows Abbott's Innovation Score is 60.8/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

How Abbott's grant cadence moved

Between 2020–2024, Abbott Cardiovascular Systems, Inc. received 101 grants versus 527 in 2015–2019 (-81% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2015 at 145 grants and bottomed in 2023 at 14. Lead class A61F accounts for 60.2% of the portfolio across 65 subclasses. Volume neighbours: Palo Alto Networks, Inc. (#703) and Lincoln Global, Inc. (#711).

Abbott's three-year grant acceleration

From 2019–2021 to 2022–2024, Abbott Cardiovascular Systems, Inc. moved from 94 to 54 grants (0.57x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,511. See the growth leaderboard.

Palo Alto Networks

646
GS Yuasa Internat…

645
Siemens Energy

645
Vanderbilt Univer…

642
Mitsubishi Materi…

640
S C Johnson & SON

640
Abbott Cardiovasc… ◀

640
MANN+Hummel

639
Lincoln Global

638

What this shows Abbott holds 640 patents at rank #707, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Abbott

By rank, the assignees closest to #707 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Abbott's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Abbott, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (61 here).

Blue Yonder Group, Inc. 61 Zhejiang University OF Technology 61 The Government of the United States of America, as represented by the Secretary of the Navy 61 ConocoPhillips Company 61

Similar claim depth

Nearest assignees by average claims per patent (16.1 here).

Faurecia Systemes D'echappement 16.1 avg Bracco Imaging S.P.A. 16.1 avg GLO AB 16.1 avg Actelion Pharmaceuticals Ltd. 16.1 avg

Abbott's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

61 Top 3% higher than 97% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Abbott Cardiovascular Systems, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	145	22.7%
2016	132	20.6%
2017	133	20.8%
2018	70	10.9%
2019	47	7.3%
2020	30	4.7%
2021	17	2.7%
2022	21	3.3%
2023	14	2.2%
2024	19	3.0%
2025partial year	12	1.9%

Which technologies does Abbott Cardiovascular Systems, Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 385

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 252

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 160

A61B - DIAGNOSIS; SURGERY; Identification 132

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 114

Y10T - Technical Subjects Covered BY Former US Classification 112

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 88

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 70

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 69

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 52

B23K - Soldering OR UNSOLDERING; WELDING; Cladding OR Plating BY Soldering OR WELDING; Cutting BY Applying Heat Locally, e.g. Flame CUTTING; Working BY Laser Beam 44

B05D - Processes FOR Applying Fluent Materials TO Surfaces, IN General 33

B23P - Metal-working NOT Otherwise Provided FOR; Combined OPERATIONS; Universal Machine Tools 22

C08L - Compositions OF Macromolecular Compounds 18

C09D - Coating Compositions, e.g. Paints, Varnishes OR LACQUERS; Filling PASTES; Chemical Paint OR INK REMOVERS; INKS; Correcting FLUIDS; WOODSTAINS; Pastes OR Solids FOR Colouring OR PRINTING; USE OF Materials Therefor 17

Top 15 of 65 technology areas

Where it ranks

Overall rank by patents

#707

of 49,997 tracked assignees

Innovation Score

60.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Abbott Cardiovascular Systems, Inc.'s patent record in context - here's where to go next.

Abbott Cardiovascular Systems, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 60.2% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #707 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Abbott Cardiovascular Systems, Inc. against Palo Alto Networks, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 60.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.